Topics

Potential Cardiovascular Blockbuster Inclisiran Among New Filings At EMA

06:27 EST 14 Feb 2020 | SCRIP

The European Medicines Agency has agreed to review pan-EU marketing applications for a number of new medicines.

      

Related Stories

 

Original Article: Potential Cardiovascular Blockbuster Inclisiran Among New Filings At EMA

NEXT ARTICLE

More From BioPortfolio on "Potential Cardiovascular Blockbuster Inclisiran Among New Filings At EMA"

Quick Search